Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

NCT00866775 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

193

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy With Simple or Complex Partial Onset Seizures

Interventions

DRUG: Eslicarbazepine acetate
DRUG: Eslicarbazepine acetate

Sponsor

Sumitomo Pharma America, Inc.